Journal articleInt J Oncol2020
PHLPP2 is a novel biomarker and epigenetic target for the treatment of vitamin C in pancreatic cancer.
- Journal
- Int J Oncol
- Published
- 25 February 2020
- Citations
- 7
- Type
- Article
These are the paper’s bibliographic details. A summary of its population, design, endpoints and findings, each tied to a quote, has not been written for this paper yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
abstract license unknown
Epigenetic dysregulations are closely associated with the development of pancreatic ductal adenocarcinoma (PDAC), which is one of the most aggressive malignancies and currently has limited treatment options. Vitamin C (VC), an epigenetic mediator, exerts antitumor effects on several types of cancer. … Excerpt only: this text is the publisher’s. Read it in full at the source.